Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshitaka Iwanaga

Showing results (1-10 of 195) with videos related to

Pageof 20
Sort By:
Anadolu Kardiyoloji Dergisi : AKD = the Anatolian Journal of Cardiology|September 6, 2007
Is BNP testing useful for detecting diastolic dysfunction?Yoshitaka Iwanaga
European Heart Journal|July 2, 2024
Oral anticoagulant use after catheter ablation for atrial fibrillation based on thrombo-embolic risk: future studies will be needed for bleeding high-risk groupKoshiro Kanaoka, Yoshitaka Iwanaga
Circulation Journal : Official Journal of the Japanese Circulation Society|June 19, 2010
Heart failure, chronic kidney disease, and biomarkers--an integrated viewpoint--Yoshitaka Iwanaga, Shunichi Miyazaki
Expert Review of Cardiovascular Therapy|October 19, 2013
Revisiting vasopressin and heart failureShinichiro Niizuma, Yoshitaka Iwanaga
Circulation Journal : Official Journal of the Japanese Circulation Society|August 27, 2009
Cystatin C in a high-risk combinationYoshitaka Iwanaga, Shunichi Miyazaki
Journal of Cardiology|July 9, 2025
Association between partial smoking ban legislation and acute coronary syndrome: A nationwide analysisMichikazu Nakai, Yoshitaka Iwanaga, Hisayoshi Fujiwara
Circulation. Cardiovascular Quality and Outcomes|October 10, 2023
No Significant Change in Trend of Hospitalizations for Acute Coronary Syndrome in Japan Before and After Introduction of Heated Tobacco ProductsHisayoshi Fujiwara, Michikazu Nakai, Yoshitaka Iwanaga
Journal of Cardiology|September 20, 2022
Current status of real-world big data research in the cardiovascular field in JapanReina Tonegawa-Kuji, Koshiro Kanaoka, Yoshitaka Iwanaga
Frontiers in Cardiovascular Medicine|March 22, 2017
Renocardiovascular Biomarkers: from the Perspective of Managing Chronic Kidney Disease and Cardiovascular DiseaseShinichiro Niizuma, Yoshitaka Iwanaga, Takaharu Yahata, et al.
Journal of Molecular and Cellular Cardiology|August 22, 2006
Down-regulation of cardiac apelin system in hypertrophied and failing hearts: Possible role of angiotensin II-angiotensin type 1 receptor systemYoshitaka Iwanaga, Yasuki Kihara, Hiroyuki Takenaka, et al.
Pageof 20

Showing results (1-10 of 195) with videos related to

Sort By:
Pageof 20
Anadolu Kardiyoloji Dergisi : AKD = the Anatolian Journal of Cardiology|September 6, 2007
Is BNP testing useful for detecting diastolic dysfunction?Yoshitaka Iwanaga
European Heart Journal|July 2, 2024
Oral anticoagulant use after catheter ablation for atrial fibrillation based on thrombo-embolic risk: future studies will be needed for bleeding high-risk groupKoshiro Kanaoka, Yoshitaka Iwanaga
Circulation Journal : Official Journal of the Japanese Circulation Society|June 19, 2010
Heart failure, chronic kidney disease, and biomarkers--an integrated viewpoint--Yoshitaka Iwanaga, Shunichi Miyazaki
Expert Review of Cardiovascular Therapy|October 19, 2013
Revisiting vasopressin and heart failureShinichiro Niizuma, Yoshitaka Iwanaga
Circulation Journal : Official Journal of the Japanese Circulation Society|August 27, 2009
Cystatin C in a high-risk combinationYoshitaka Iwanaga, Shunichi Miyazaki
Journal of Cardiology|July 9, 2025
Association between partial smoking ban legislation and acute coronary syndrome: A nationwide analysisMichikazu Nakai, Yoshitaka Iwanaga, Hisayoshi Fujiwara
Circulation. Cardiovascular Quality and Outcomes|October 10, 2023
No Significant Change in Trend of Hospitalizations for Acute Coronary Syndrome in Japan Before and After Introduction of Heated Tobacco ProductsHisayoshi Fujiwara, Michikazu Nakai, Yoshitaka Iwanaga
Journal of Cardiology|September 20, 2022
Current status of real-world big data research in the cardiovascular field in JapanReina Tonegawa-Kuji, Koshiro Kanaoka, Yoshitaka Iwanaga
Frontiers in Cardiovascular Medicine|March 22, 2017
Renocardiovascular Biomarkers: from the Perspective of Managing Chronic Kidney Disease and Cardiovascular DiseaseShinichiro Niizuma, Yoshitaka Iwanaga, Takaharu Yahata, et al.
Journal of Molecular and Cellular Cardiology|August 22, 2006
Down-regulation of cardiac apelin system in hypertrophied and failing hearts: Possible role of angiotensin II-angiotensin type 1 receptor systemYoshitaka Iwanaga, Yasuki Kihara, Hiroyuki Takenaka, et al.
Pageof 20